NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cellular Origins

Cellular Origins

Private
MelbournHealthcare & Life Scienceshttps://cellularorigins.com/

Last Round

Series A

Dec 9, 2025

Total Funding Raised

$40M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cellular Origins is a biotechnology company that provides a robotic automation platform, Constellation, designed for the scalable, cost-effective, and efficient manufacture of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Industrial Robotics, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

advanced therapy medicinal productsATMPcell therapy manufacturinggene therapy manufacturingbioprocessing automationrobotic manufacturing platformlab automationbiotech roboticsCDMOcontract development and manufacturing organizationbiomanufacturingclosed-system manufacturingbiotech scalingsmart manufacturingbioprocess orchestration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellular Origins Comps

Public and private peers based on sector, stage, and business model.

Cellular Origins comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellular Origins Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 9, 2025

Key People

Founding team and executive leadership

Dan Strange

Chief Technology Officer

Executive Team

Peter Crossley

Chief Operating Officer

Executive Team

Cellular Origins Investors

Notable investors and investment history

Cellular Origins investors
InvestorRounds
TTP GroupSeries A
BGFSeries A
Johnson & Johnson Innovation – JJDCSeries A
Johnson & Johnson Innovation - JJDC, Inc.Series A
NYBC VenturesSeries A
Highland EuropeSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 30, 2026

    Grew 16% QoQ, from 90 to 104 employees.

  • May 20, 2026

    Grew 19% QoQ, from 85 to 101 employees.

Cellular Origins Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellular Origins Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellular Origins's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourn
Employee Range104
Year Founded2022
Last FundingDec 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.